Keeping an eye on vision: new tools to preserve sight and quality of life. A roundtable discussion, Part 2.
Research is pointing the way to new therapies for the eye diseases of aging. A gene that appears related to glaucoma has been identified, and a safe and effective inhibitor for aldose reductase is being sought for patients with diabetic retinopathy. Refinements in cataract surgery continue to improve the high success rate of this procedure. Physicians can educate their patients to participate in vision protection, through control of blood sugars, compliance with glaucoma medications, and the use of the Amsler grid by those at risk for macular degeneration. When vision cannot be corrected to the normal range, low vision rehabilitation offers magnification and new high-tech devices for optimizing independent patient function.
Butler
R N
RN
Department of Geriatrics and Adult Development, Mount Sinai Medical Center, New York, USA.
Faye
E E
EE
Guazzo
E
E
Kupfer
C
C
D000367:Age Factors; D000368:Aged; D002386:Cataract / Q000209:etiology / Q000517:prevention & control; D003930:Diabetic Retinopathy / Q000209:etiology / Q000517:prevention & control; D005128:Eye Diseases / Q000175:diagnosis / Q000517:prevention & control*; D005260:Female; D005901:Glaucoma / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D008268:Macular Degeneration / Q000209:etiology / Q000517:prevention & control; D008297:Male; D012106:Research; D012307:Risk Factors; D014786:Vision Disorders / Q000209:etiology / Q000534:rehabilitation*